AndreaBozzo/ceres-open-data-index huggingface dataset:
Access and Use of Telemedicine During COVID-19

The Research and Development Survey (RANDS) is a platform designed for conducting survey question evaluation and statistical research. RANDS is an ongoing series of surveys from probability-sampled commercial survey panels used for methodological research at the National Center for Health Statistics (NCHS). RANDS estimates are generated using an experimental approach that differs from the survey design approaches generally used by NCHS, including possible biases from different response patterns and sampling frames as well as increased variability from lower sample sizes. Use of the RANDS platform allows NCHS to produce more timely data than would be possible using traditional data collection methods. RANDS is not designed to replace NCHS’ higher quality, core data collections. Below are experimental estimates of telemedicine access and use for three rounds of RANDS during COVID-19. Data collection for the three rounds of RANDS during COVID-19 occurred between June 9, 2020 and July 6, 2020, August 3, 2020 and August 20, 2020, and May 17, 2021 and June 30, 2021. Information needed to interpret these estimates can be found in the Technical Notes. RANDS during COVID-19 included questions about whether providers offered telemedicine (including video and telephone appointments) in the last 2 months—both during and before the pandemic—and about the use of telemedicine in the last 2 months during the pandemic. As a result of the coronavirus pandemic, many local and state governments discouraged people from leaving their homes for nonessential reasons. Although health care is considered an essential activity, telemedicine offers an opportunity for care without the potential or perceived risks of leaving the home. The National Health Interview Survey, conducted by NCHS, added telemedicine questions to its sample adult questionnaire in July 2020.  The Household Pulse Survey (https://www.cdc.gov/nchs/covid19/pulse/telemedicine-use.htm), an online survey conducted in response to the COVID-19 pandemic by the Census Bureau in partnership with other federal agencies including NCHS, also reports estimates of telemedicine use during the pandemic (beginning in Phase 3.1, which started on April 14, 2021). The Household Pulse Survey reports telemedicine use in the last 4 weeks among adults and among households with at least one child under age 18 years. The experimental estimates on this page are derived from RANDS during COVID-19 and show the percentage of U.S. adults who have a usual place of care and a provider that offered telemedicine in the past 2 months, who used telemedicine in the past 2 months, or who have a usual place of care and a provider that offered telemedicine prior to the coronavirus pandemic. Technical Notes: https://www.cdc.gov/nchs/covid19/rands/telemedicine.htm#limitations
Compound 529926: Nilvadipine M (dehydro)

Chemical compound data from PubChem database. IUPAC Name: 5-O-methyl 3-O-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Molecular Formula: C19H17N3O6. Molecular Weight: 383.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400470-T1: [Translated] METHOD AND HEADLIGHT FOR MODULATED LIGHTING OF A ROAD

The process involves detecting an individual in a road. The individual in the scene of the road is localized. A mask corresponding to dimension and position of the individual is created on a display. A cast shadow (OP) is created around the individual by lighting the road through the display. A zone of the scene of road situated above a gap is lighted. An independent claim is also included for a road lighting headlight of a vehicle.
Healthcare Cost and Utilization Project (HCUP) Summary Trends Tables

The HCUP Summary Trend Tables include monthly information on hospital utilization derived from the HCUP State Inpatient Databases (SID) and HCUP State Emergency Department Databases (SEDD). Information on emergency department (ED) utilization is dependent on availability of HCUP data; not all HCUP Partners participate in the SEDD.

The HCUP Summary Trend Tables include downloadable Microsoft® Excel tables with information on the following topics:

<li>Overview of monthly trends in inpatient and emergency department utilization
<li>All inpatient encounter types
<li>Inpatient stays by priority conditions
-COVID-19
-Influenza
-Other acute or viral respiratory infection
<li>Inpatient encounter type
-Normal newborns
-Deliveries
-Non-elective inpatient stays, admitted through the ED
-Non-elective inpatient stays, not admitted through the ED
-Elective inpatient stays
<li>Inpatient service line
-Maternal and neonatal conditions
-Mental health and substance use disorders
-Injuries
-Surgeries
-Other medical conditions
<li>Emergency department treat-and-release visits
<li>Emergency department treat-and-release visits by priority conditions
-COVID-19
-Influenza
-Other acute or viral respiratory infection
<li>Description of the data source, methodology, and clinical criteria
Ethacrynate sodium

Ethacrynate Sodium is a prescription loop diuretic medication used to treat fluid retention (edema) by increasing urine production. It comes as a lyophilized powder for intravenous injection, with each vial containing 50 mg of the active ingredient. Manufactured by Leading Pharma, LLC, under application ANDA208663. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E401283-T1: [Translated] CATCHING DEVICE FOR A GRADUATE BIDIRECTIONAL SAFETY DEVICE

Catch system for a gradual bi-directional elevator safety device based on the use of a roller together with hinged rectangular frames on which a friction element is placed, thereby preventing to mark the guiderails during the braking, its operation being such that initially the displacement of the roller produces the braking action on the guide and the catching of the rectangular frame, while subsequently said frame brakes the guiderail, without the participation of the roller (9) and with the aid of fixed brake shoes placed opposite the hinged rectangular frames.
Compound 526272: 1,3,6,7-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,6,7-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials

Background
          Language bias is a form of publication bias and constitutes a serious threat to meta-analyses. The Cochrane Controlled Trials Register is one attempt to remedy this and now contains more than 300,000 citations. However we are still unsure if it provides comprehensive coverage, particularly for non-English trials.
        
        
          Methods
          We have recently established a comprehensive register of Japanese trials of psychotropic drugs through extensive personal contacts, electronic searches and handsearches. We examined two Cochrane psychiatry group registers against this Japanese database.
        
        
          Results
          The Japanese register contained 56 reports of randomized controlled trials (RCTs) of antidepressants for depression but the Cochrane Depression, Anxiety and Neurosis group register contained 18, with an overlap of only nine. The Japanese register contained 61 reports of RCTs of neuroleptics for schizophrenia and the Cochrane Schizophrenia group register contained 36, with an overlap of only six. Taking account of some duplicate publications, only a quarter to a third of all relevant Japanese RCTs were retrievable from the Cochrane group registers.
        
        
          Conclusions
          Similar, or worse, yields may be expected with RCTs conducted in other East Asian countries, and in other fields of medicine. What evidence there is suggests that this situation may lead to a systematic over estimate of treatment effect.
Deaths by Selected Causes of Death, Sex and Age, New York State: Beginning 2018

This dataset contains the number of New York State deaths from selected causes by jurisdiction, sex and age group. The data presented here may differ from the Vital Statistics tables on the Department public website due to data updates. For more information, visit  https://www.health.ny.gov/statistics/vital_statistics/vs_reports_tables_list.htm,  where information from this dataset is presented in tabular form in Table 41.
National Mental Health Services Survey (N-MHSS): 2012, Data on Mental Health Treatment Facilities

This an annual report that presents findings from the 2012 National Mental Health Services Survey (N-MHSS) conducted from September 2012 through February 2013. The N-MHSS collects information from all the known facilities in the United States, both public and private, that provide mental health treatment services to people with mental illness. The N-MHSS is designed to collect data on the location, characteristics, and utilization of organized mental health treatment service providers throughout the 50 states, the District of Columbia, and the U.S. territories.
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture — primary culture cells markedly differ from fourth-passage cells

To reduce culture artifacts by conventional repeated passaging and long-term culture in vitro, the isolation of synovial fibroblasts (SFB) was attempted from rheumatoid arthritis (RA) synovial membranes by trypsin/collagenase digest, short-term in vitro adherence (7 days), and negative isolation using magnetobead-coupled anti-CD14 monoclonal antibodies. This method yielded highly enriched SFB (85% prolyl-4-hydroxylase+/74% Thy-1/CD90+ cells; <2% contaminating macrophages; <1% leukocytes/endothelial cells) that, in comparison with conventional fourth-passage RA-SFB, showed a markedly different phenotype and significantly lower proliferation rates upon stimulation with platelet-derived growth factor and IL-1β. This isolation method is simple and reliable, and may yield cells with features closer to the in vivo configuration of RA-SFB by avoiding extended in vitro culture.
Patent AT-E401389-T1: [Translated] TRANSGENIC ANIMAL MODELS WITH ALTERED PHENOTYPE FOR ALZHEIMER'S DISEASE

A method of preparing a transgenic animal model with enhanced, accelerated pathology for Alzheimer's Disease (AD) and the transgenic animal made by the method is disclosed. The method includes producing an F1 generation by crossing a first and second transgenic parent each carrying a different expressible transgene for differing aspects of the same desired phenotype associated with AD pathology. The offspring of the F1 generation are then screened and those which carry a transgene from each parental transgenic animal resulting in an enhanced pathology for Alzheimer's Disease are selected. In a preferred embodiment the AD-associated pathology is for amyloid accumulation. In an embodiment a mutant presenilin transgene and a transgene for a mutant amyloid precursor protein are used. In a further embodiment the mutant presenilin transgene is the PS1 M146L mutation and the mutant amyloid precursor protein transgene is the Swedish mutation (APP695 isoform containing a K670N,M671L mutation (APP770 numbering)).
Compound 525049: 3'-Chloro,4'-methylenanthoanilide

Chemical compound data from PubChem database. IUPAC Name: N-(3-chloro-4-methylphenyl)heptanamide. Molecular Formula: C14H20ClNO. Molecular Weight: 253.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530486: m-Anisic acid, cyclobutyl ester

Chemical compound data from PubChem database. IUPAC Name: cyclobutyl 3-methoxybenzoate. Molecular Formula: C12H14O3. Molecular Weight: 206.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NYTD Technical Assistance to States

Tailored technical assistance (TA) is available to states that are working with the Children’s Bureau to plan for their NYTD Review on ways to engage young adults (ages 18−25) with current or former foster care experience to participate as a state NYTD Reviewer (called State Youth Ambassador) and in their state’s ongoing NYTD efforts. The goal is to build capacity within the state through the involvement of young people in their NYTD and CQI efforts.

General TA support available:

To schedule a NYTD Review TA call, please contact our TA team by emailing the Child Welfare Compliance Reviews Team at cw@jbsinternational.com, Subject: NYTD TA

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525601: N,N-Dimethyl-N'-(4-methoxyphenyl)-p-methylbenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-methoxyphenyl)-N,N,4-trimethylbenzenecarboximidamide. Molecular Formula: C17H20N2O. Molecular Weight: 268.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Miami - Dade Div: Drug-Related Emergency Department Visits, 2004-2011 - Accidental Ingestions

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving accidental ingestions in the Miami metropolitan area, Dade County division. This analytic category includes ED visits in which an individual accidentally or unknowingly used or was administered a prescription drug, over-the-counter medication, or dietary supplement. Drug-related accidental ingestion typically involves patients aged 5 and under.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Macrophages in rheumatoid arthritis

The abundance and activation of macrophages in the inflamed synovial membrane/pannus significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be the 'initiators' of RA (if not as antigen-presenting cells in early disease), macrophages possess widespread pro-inflammatory, destructive, and remodeling capabilities that can critically contribute to acute and chronic disease. Also, activation of the monocytic lineage is not locally restricted, but extends to systemic parts of the mononuclear phagocyte system. Thus, selective counteraction of macrophage activation remains an efficacious approach to diminish local and systemic inflammation, as well as to prevent irreversible joint damage.
Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 7 - Kansas City

Source for 2012 national data: National Occupant Protection Use Survey (NOPUS), 2012. Source for 2014 national data: National Occupant Protection Use Survey (NOPUS), 2014.  Source for 2012 state data: State Observational Survey of Seat Belt Use, 2012. Source for 2014 state data: Seat Belt Use in 2014- Use Rates in the States and Territories
Compound 528224: 1,14-Dichloro-3,9-dithia-6,12-dioxatetradecane

Chemical compound data from PubChem database. IUPAC Name: 1-[2-(2-chloroethoxy)ethylsulfanyl]-2-[2-(2-chloroethylsulfanyl)ethoxy]ethane. Molecular Formula: C10H20Cl2O2S2. Molecular Weight: 307.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401295-T1: [Translated] AMORPHOUS SALTS OF CALCIUM CITRATE AND METHOD FOR THE PRODUCTION AND USE THEREOF

Chemical patent from PubChem database. Patent Number: AT-E401295-T1. Title: Sustained Release Formulation. Filing Date: 2002-09-05. Inventors: Chen, Wei, Kumar, Raj, Williams, Sarah. Abstract: A sustained release formulation is provided, designed to maintain therapeutic drug levels over extended periods, reducing dosing frequency and improvi... IPC Classifications: C07C, C07B, A61K. This patent covers 11 claims related to 9 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries

Background
          This study assessed women and providers' satisfaction with a new evidence-based antenatal care (ANC) model within the WHO randomized trial conducted in four developing countries. The WHO study was a randomized controlled trial that compared a new ANC model with the standard type offered in each country. The new model of ANC emphasized actions known to be effective in improving maternal or neonatal health, excluded other interventions that have not proved to be beneficial, and improved the information component, especially alerting pregnant women to potential health problems and instructing them on appropriate responses. These activities were distributed within four antenatal care visits for women that did not need any further assessment.
        
        
          Methods
          Satisfaction was measured through a standardized questionnaire administered to a random sample of 1,600 pregnant women and another to all antenatal care providers.
        
        
          Results
          Most women in both arms expressed satisfaction with ANC. More women in the intervention arm were satisfied with information on labor, delivery, family planning, pregnancy complications and emergency procedures. More providers in the experimental clinics were worried about visit spacing, but more satisfied with the time spent and information provided.
        
        
          Conclusions
          Women and providers accepted the new ANC model generally. The safety of fewer visits for women without complications with longer spacing would have to be reinforced, if such a model is to be introduced into routine practice.
Compound 525606: N,N-Dimethyl-N'-(4-nitrophenyl)-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-(4-nitrophenyl)benzenecarboximidamide. Molecular Formula: C15H15N3O2. Molecular Weight: 269.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.

Background
          In Southeast Asia, dengue viruses often co-circulate with other flaviviruses such as Japanese encephalitis virus, and due to the presence of shared antigenic epitopes it is often difficult to use serological methods to distinguish between previous infections by these flaviviruses.
        
        
          Results
          Convalescent sera from 69 individuals who were known to have had dengue or Japanese encephalitis virus infection were tested by western blotting against dengue, Japanese encephalitis and West Nile virus antigens. We determined that individuals who had been infected with dengue viruses had IgG responses against the premembrane protein of dengue viruses but not Japanese encephalitis, whereas individuals who had been infected with Japanese encephalitis had IgG specific for the premembrane protein of Japanese encephalitis virus but not the dengue viruses. None reacted with the premembrane protein of West Nile virus. Using the Pearson Chi Square test, it was determined that the difference between the two groups was highly significant with a p value of <0.001.
        
        
          Conclusion
          The use of flavivirus premembrane protein in seroepidemiological studies will be useful in determining what flaviviruses have circulated in a community.
Supporting Evidence-Based Home Visitation Programs to Prevent Child Abuse and Neglect Project: Minnesota Department of Health State Treasurer

Location:

To be determined

Home Visiting Program Selected:

Nurse Family Partnership

Home Visiting Target Population:

Families at risk for child maltreatment, including first-time parents and parents who have recently added a newborn to their family

Project Overview:
Minnesota plans a two-pronged approach to enhance, expand and sustain evidence-based home visiting programs through infrastructure development and a targeted population implementation project. To strengthen the infrastructure supporting home visiting service delivery, Minnesota will establish a system for reimbursement of evidence-based home visiting programs through publicly funded health programs; engage in joint planning to blend funding streams; award mini-grants to support startup costs for Nurse Family Partnership (NFP) implementation; and provide reflective practice, supervision, and technical assistance for new and current NFP sites. Minnesota will also implement NFP with American Indians and/or a non-English speaking immigrant/ refugee population (Hmong), two populations in Minnesota experiencing health disparities that have not previously been included in NFP randomized trials. Minnesota will work with the NFP National Office to explore the proposed adaptation of materials for the identified target population. As part of this targeted population implementation project, Minnesota will explore the feasibility of evaluating home visits delivered by a bilingual nurse compared to home visits provided by an English-speaking nurse and an interpreter.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 526263: 1,3,4,6,8-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,4,6,8-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Physician Orders for Life-Sustaining Treatment (POLST)

The California Department of Public Health (CDPH) has created a file of the prevalence of Physician Orders for Life-Sustaining Treatment (POLST) documents in California, limited to residents in skilled nursing facilities (SNF).  This file enables a comparison of the proportion of nursing home residents that are reported to have a completed POLST form in their medical chart, by county and year, between January 1, 2011 and December 31, 2023.  POLST treatment preferences are actionable as a Doctor’s Order if accompanied with the signatures of either the patient or a legally recognized decision maker, and that of a physician, nurse practitioner or physician assistant.  Counts of nursing homes and of distinct nursing home residents are also provided. 

Visuals include percentages of California skilled nursing facility residents with completed or unsigned POLST forms statewide and by county, and completion of medical treatment sections of signed POLST forms statewide and by county.

Resources include POLST forms and All Facility Letters (AFL) sent by CDPH to facilities regarding POLST and Section S information.